Literature DB >> 3090599

Effect of l-tetrahydropalmatine on dopamine release and metabolism in the rat striatum.

F Marcenac, G Z Jin, F Gonon.   

Abstract

In vivo voltammetric measurements of striatal extracellular DOPAC concentrations and of striatal DA release in combination with post-mortem analysis of striatal catechols were performed in the rat to study the effects on the nigro-striatal neurons of a Chinese neuroleptic, l-tetrahydropalmatine (l-THP), which is known to block post-synaptic dopaminergic receptors. l-THP injected at doses that cause sedation in rats and mice (5-10 mg/kg) induced a marked increase in post-mortem DOPAC levels (+250%), while no significant effect was observed on postmortem DA levels. The extracellular DOPAC concentration was increased to 155 +/- 9% of the control value after l-THP administration (1 mg/kg, IP). Further, an injection of l-THP (1 mg/kg, IP) induced an increase in extracellular DA concentration (220% of the basal value), reversed the decrease in extracellular DA concentration induced by apomorphine (0.05 mg/kg, SC) and enhanced the effects of the electrical stimulation of the nigro-striatal pathway. These results confirm that l-THP acts on the nigro-striatal neurons as a dopaminergic antagonist that can block both post- and presynaptic receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090599     DOI: 10.1007/bf00175196

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  FURTHER STUDIES ON THE PHARMACOLOGY OF TETRAHYDROPALMATINE AND ITS ANALOGS.

Authors:  B HSU; K C KIN
Journal:  Int J Neuropharmacol       Date:  1963-12

2.  Pharmacological study of tetrahydropalmatine and its analogs. A new type of central depressants.

Authors:  B HSU; K C KIN
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-10-01

3.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

4.  Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry.

Authors:  F G Gonon
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

5.  [Relevance of the sedative-tranquilizing effect of l-tetrahydropalmatine to brain monoaminergic neurotransmitters].

Authors:  G Z Jin; J Xu; F T Zhang; L P Yu; J H Li; X L Wang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1983-03

6.  In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry.

Authors:  F G Gonon; F Navarre; M J Buda
Journal:  Anal Chem       Date:  1984-03       Impact factor: 6.986

7.  [Differentiation between catalepsies induced by l-tetrahydropalmatine and by haloperidol and morphine (author's transl)].

Authors:  J Xu; G Z Jin; L P Yu; X J Liu
Journal:  Zhongguo Yao Li Xue Bao       Date:  1981-09

8.  Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum.

Authors:  F G Gonon; M J Buda
Journal:  Neuroscience       Date:  1985-03       Impact factor: 3.590

9.  Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry. I. Nature and origin of contributors to the oxidation current at +0.1 V.

Authors:  M Buda; G De Simoni; F Gonon; J F Pujol
Journal:  Brain Res       Date:  1983-08-29       Impact factor: 3.252

10.  Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

Authors:  J Lehmann; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

  10 in total
  10 in total

1.  Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in naïve rats detected at 9.4 T.

Authors:  Xiping Liu; Zheng Yang; Rupeng Li; Jun Xie; Qian Yin; Alan S Bloom; Shi-Jiang Li
Journal:  Magn Reson Imaging       Date:  2011-11-12       Impact factor: 2.546

Review 2.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

Review 3.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

5.  Plants with Anti-Addictive Potential.

Authors:  Eduardo Luis Konrath; Marcelo Dutra Arbo; Bruno Dutra Arbo; Mariana Appel Hort; Elaine Elisabetsky; Mirna Bainy Leal
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.

Authors:  Yazmin Figueroa-Guzman; Christopher Mueller; Oliver Vranjkovic; Samantha Wisniewski; Zheng Yang; Shi-Jiang Li; Colin Bohr; Evan N Graf; David A Baker; John R Mantsch
Journal:  Drug Alcohol Depend       Date:  2010-12-31       Impact factor: 4.492

7.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

8.  Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

Authors:  Zheng-Xiong Xi; Zheng Yang; Shi-Jiang Li; Xia Li; Christopher Dillon; Xiao-Qing Peng; Krista Spiller; Eliot L Gardner
Journal:  Neuropharmacology       Date:  2007-08-15       Impact factor: 5.250

9.  l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats.

Authors:  Shamia L Faison; Charles W Schindler; Steven R Goldberg; Jia Bei Wang
Journal:  BMC Pharmacol Toxicol       Date:  2016-11-07       Impact factor: 2.483

10.  Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine.

Authors:  Soyon Ahn; Maya O Nesbit; Haiyan Zou; Giada Vacca; Peter Axerio-Cilies; Tran Van Sung; Anthony G Phillips
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.